STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $125,000 | -92.9% | 11,802 | -93.6% | 0.00% | -100.0% |
| Q4 2018 | $1,761,000 | -38.0% | 185,395 | +8.3% | 0.00% | 0.0% |
| Q3 2018 | $2,841,000 | -0.4% | 171,120 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $2,853,000 | -14.1% | 177,731 | -18.1% | 0.00% | 0.0% |
| Q1 2018 | $3,322,000 | -1.9% | 217,129 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,387,000 | +39.2% | 217,129 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $2,434,000 | +119.7% | 219,252 | +82.0% | 0.00% | 0.0% |
| Q2 2017 | $1,108,000 | +88.1% | 120,477 | +74.9% | 0.00% | – |
| Q1 2017 | $589,000 | -30.9% | 68,899 | -13.6% | 0.00% | – |
| Q4 2016 | $853,000 | -3.7% | 79,719 | -2.6% | 0.00% | – |
| Q3 2016 | $886,000 | +281.9% | 81,819 | +138.3% | 0.00% | – |
| Q2 2016 | $232,000 | +241.2% | 34,337 | +133.9% | 0.00% | – |
| Q1 2016 | $68,000 | – | 14,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |